Search the Newsreel

Candel Therapeutics, Inc. Q2 2026: Net income $(38.9M), EPS $(0.52) — 10-Q Summary

Candel Therapeutics, Inc. reported a widened net loss for Q2 2026, with net income at $(38.9M) and diluted EPS at $(0.52), due to continued investments in clinical programs. The company remains pre-revenue but expects its cash reserves to fund operations and trials into Q1 …

Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Candel Therapeutics announced its Q2 2026 financial results, highlighting significant progress in its clinical programs. The company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec for prostate cancer in Q4 2026 and has initiated a pivotal Phase 3 trial for NSCLC. …

Candel Therapeutics (NASDAQ: CADL) widens H1 2026 loss while boosting cash above $200M

Form 8K Candel Therapeutics Inc For: 13 August By Investing.com

This article announces that Candel Therapeutics Inc. filed a Form 8K on August 13th, as reported by Investing.com. The brief piece includes the company's stock symbol CADL and its performance for the day. No further details about the Form 8K content are provided within …

Candel Therapeutics reports Q2 2026 net loss $38.9M, cash $201.6M; plans BLA submission Q4 2026

Candel Therapeutics reported a net loss of $38.9 million for Q2 2026, with $201.6 million in cash and equivalents, expected to fund operations into Q1 2028. The company plans to submit a Biologics License Application for aglatimagene in prostate cancer in Q4 2026, highlighting …

Candel Therapeutics GAAP EPS of -$0.52 misses by $0.29

* Candel Therapeutics press release [https://seekingalpha.com/pr/20618191-candel-therapeutics-reports-second-quarter-2026-financial-results-and-recent-corporate] (CADL [https://seekingalpha.com/symbol/CADL]): Q2 GAAP EPS of -$0.52 misses by $0.29. * Cash and cash equivalents of $201.6 million, as of June 30, 2026, are expected to be sufficient to fund the Company’s current operating plan into Q1 2028, …

Candel's Prostate Therapy Candidate Shows 39% Disease-Free Survival Improvement

Candel Therapeutics announced its second-quarter 2026 financial results, reporting a net loss of $38.9 million. The company highlighted significant clinical progress, including a planned Biologics License Application (BLA) submission in Q4 2026 for aglatimagene besadenovec in prostate cancer, supported by phase 3 data showing …

Santander repurchases 20 million shares in buyback program

Banco Santander S.A. has repurchased 20 million of its own shares between Wednesday and Tuesday, as part of a buyback program announced in February 2026. The Spanish bank executed these transactions across XMAD and CEUX exchanges at weighted average prices between €12.8441 and €12.9676 …

Highlander Silver (HSLV) posts $56M revenue and profit after Bear Creek acquisition

Banco Santander (SAN) invests €4.65B to repurchase 17.8% of shares

Banco Santander (SAN) has nearly completed its share repurchase program, investing €4.65 billion to buy back approximately 92.5% of the authorized amount. Between August 6 and 12, 2026, the bank repurchased 20 million shares at weighted average prices ranging from €12.84 to €12.97. Cumulatively, …

REG - Banco Santander S.A. - Buyback programme: transactions 6-12 Aug

Banco Santander S.A. has announced the transactions carried out under its share buyback program between August 6 and August 12, 2026. The bank has purchased 20 million shares during this period, with the total cash amount for shares bought reaching 4,650,490,891 Euros, representing approximately …

Banco Santander Brasil SA Analyst Predictions | Analyst Consensus, Estimates & Rating Changes

This page provides an overview of Banco Santander Brasil SA (BSBR) stock, including its current trading price, market capitalization, key financial metrics like PE ratio and EPS, and dividend information. It also details trading activity such as daily range, volume, and 52-week range, alongside …

Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates

Andersons (ANDE) Reports Record Renewables Earnings, Is The Stock Still Undervalued?

Andersen reaffirms 2026 revenue of $980M-$1B and adjusted EBITDA margin of 22%-23% while inorganic revenue slows

Earnings Call Insights: Andersen Group Inc. (ANDG) Q2 2026 MANAGEMENT VIEW * Mark Vorsatz (Chairman & CEO) said, “we had a very solid second quarter,” and reported Q2 revenue of “about $217.7 million,” adding, “that’s an increase of 23.7%” with “organic growth rate …

Standex International (SXI) awards 2,285 RSUs to senior executive

Standex International (SXI) has granted 2,285 Restricted Stock Units (RSUs) to Richard Colby Slaughter, CLO, VP, and Secretary, on August 10, 2026. These RSUs, tied to common stock, will vest in three equal installments on August 10, 2027, 2028, and 2029. Following this award, …

Standex International (SXI) officer Slaughter files initial Form 3 insider report

Richard Colby Slaughter, CLO, Vice President, and Secretary of Standex International Corp. (SXI), has filed an initial statement of beneficial ownership (Form 3). This filing establishes Slaughter as a reporting person but does not indicate any current equity holdings or transactions in company securities. …

Banco Santander-Chile (BSAC) reports MCh$71.3B in assets and solid net income

Andersen Group Delivers Record Second-Quarter Revenue of $217.7 Million

Andersen Group Inc. reported record second-quarter revenue of $217.7 million, a 23.7% increase year-over-year, and six-month revenue of $458.4 million, up 19.4%. The growth was broad-based across all service lines, driven by client additions and service expansion. The company also reaffirmed its full-year 2026 …

Andersen Group's Revenue Tops $458M as All Service Lines Grow

Kayne Anderson BDC Releases Q2 2026 Financial Results

Kayne Anderson BDC (KBDC) announced its Q2 2026 financial results, reporting basic and diluted earnings of $0.16 per share, significantly missing the $0.41 consensus estimate by 61.0%. The asset management company recorded a net income of $10.7 million for the quarter, operating 104 portfolio …

Candel Therapeutics at canaccord growth conference: prostate cancer push

Candel Therapeutics (CADL) presented its viral immunotherapy pipeline at Canaccord Genuity’s 46th Annual Growth Conference, focusing on significant clinical momentum in localized prostate cancer. The company highlighted positive late-stage data for aglatimagene besadenovec in prostate cancer, aiming for a biologics license application by late …

Earnings call transcript: Andean Precious Metals posts Q2 2026 loss, shares fall

Die Banco-Santander-Aktie reagiert auf starke Quartalszahlen und stabile Analystenerwartungen

Andean Precious Metals Corp. 2026 Q2 - Results - Earnings Call Presentation (TSX:APM:CA) 2026-08-12

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Tandem Diabetes Care (TNDM) reported a Q2 2026 loss of 31 cents per share, which was narrower than expected, though worldwide revenues of $254.6 million missed consensus estimates. Despite the revenue miss, the company's shares rose 19.1% after the announcement, driven by increased pump …

Earnings Flash (APM.TO) Andean Precious Metals Corp. Reports Q2 Revenue $67.6M

The Andersons, Inc. (NASDAQ:ANDE) Receives Consensus Recommendation of "Buy" from Analysts

The Andersons, Inc. (NASDAQ:ANDE) has received a consensus "Buy" recommendation from analysts, with an average 12-month price target of $95.00, significantly higher than its current share price. The company reported strong quarterly earnings per share of $2.15, surpassing estimates, despite a slight year-over-year revenue …

Wasatch Advisors LP Trims Stock Holdings in Standex International Corporation $SXI

Wasatch Advisors LP significantly reduced its stake in Standex International Corporation by 35.8% in Q2 2026, selling 470,971 shares but still holding 6.99% of the company's stock. Despite this reduction, other institutional investors increased their positions, and 90.35% of the stock is owned by …

Renaissance Technologies LLC Acquires 73,322 Shares of Kayne Anderson BDC, Inc. $KBDC

Renaissance Technologies LLC significantly increased its stake in Kayne Anderson BDC, Inc. (NYSE:KBDC) by over 101% in the first quarter, purchasing an additional 73,322 shares to reach a total of 145,322 shares valued at approximately $1.99 million. This move, along with other institutional investments, …

Kayne Anderson BDC Inc (KBDC) Stock News Today

This article provides current stock news for Kayne Anderson BDC Inc (KBDC), including its stock price, market cap, P/E ratio, and recent performance. The platform offers an overview, financial data, and analyst ratings, noting that more news will be added soon.

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings

Tandem Diabetes Care, Inc. (TNDM) presents a high-risk, high-reward investment opportunity in the medical devices industry, with analysts projecting a 25% potential upside and no sell ratings. Despite current financial challenges like negative EPS and free cash flow, the company is bullishly positioned above …

Andean Precious Metals Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Standex International Corporati (SXI) Stock forecasts

Argus has lowered its target price for Standex International Corp (SXI) to $325.00, according to a report published on July 29, 2026. Standex International is an industrial manufacturer serving commercial and industrial markets. The current price of SXI is $333.02.

Banco Santander Chile (BSAC) (Q2 2026) Earnings Call Highlights: Record Profitability and ...

This article first appeared on GuruFocus. Net Income: CLP382.6 billion in Q2 2026, up 40% Q-on-Q and 40% year-on-year. Return on Average Equity (ROAE): 31.5% in Q2 2026 and 27.2% year-to-date. Total Loans: CLP41.4 trillion, up 1.2% year-to-date and 1.3% quarter-on-quarter. Total Deposits: CLP32.4 …

Banco Santander Brasil (NYSE:BSBR) Insider Sells $169,348.22 in Stock

An insider at Banco Santander Brasil (NYSE:BSBR), Celso Mateus De Queiroz, sold 29,299 shares of the company's stock for $169,348.22, reducing his direct ownership by over 55%. The bank's stock recently traded down 0.3% at $5.75, while it also announced a quarterly dividend of …